We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation (TOP RACER)

This study is not yet open for participant recruitment.
Verified March 2013 by Francesco Pelliccia, University of Roma La Sapienza
Sponsor:
ClinicalTrials.gov Identifier:
NCT01638078
First Posted: July 11, 2012
Last Update Posted: March 7, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Francesco Pelliccia, University of Roma La Sapienza
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)